688276 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Changchun BCHT Biotechnology Co. engages in the research and development, production and sale of human vaccines. It specializes in prevention and treatment of infectious diseases. Its products include chickenpox vaccine, rabies vaccine, and freeze-dried nasal spray flu vaccine. The company was founded on March 4, 2004 and is headquartered in Changchun, China.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
688276 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company